[Magnetic resonance imaging of the brain in the monitoring of immune therapy of multiple sclerosis]. / Aivojen magneettikuvaus MS-taudin immunologisen hoidon seurannassa.
Duodecim
; 131(17): 1571-80, 2015.
Article
em Fi
| MEDLINE
| ID: mdl-26548104
ABSTRACT
Magnetic resonance imaging of the brain is currently the most sensitive method in detecting the lesions caused by multiple sclerosis. Assessment of the immunological treatment response used in the treatment of multiple sclerosis should be based on the clinical picture and brain MRI. T2-, flair- and T1-biased images, gadolinium enhancement and assessment of atrophy are required for MRI monitoring. In the first-line immune therapy MRI is taken at 6 to 12 months after starting the drug therapy, in fingolimod therapy after 6 to 12 months and 1 to 2 years, respectively, and in alemtuzumab and natalizumab therapy after one and two years.
Buscar no Google
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Imageamento por Ressonância Magnética
/
Imunoterapia
/
Esclerose Múltipla
Limite:
Humans
Idioma:
Fi
Revista:
Duodecim
Ano de publicação:
2015
Tipo de documento:
Article